Biomarkers in Cardiorenal Syndrome

Giovanni Goffredo1,2, Roberta Barone1,2, Vito Di Terlizzi1,2

  • 1Department of Medical and Surgical Sciences, University of Foggia, Viale Luigi Pinto 1, 71122 Foggia, Italy.

Insights

Cardiorenal syndrome involves complex heart and kidney interactions. This review explores new biomarkers to assess kidney function and predict worsening in cardiovascular patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarker Research

Background:

  • Cardiorenal syndrome (CRS) highlights the intricate relationship between heart and kidney diseases.
  • Accurate assessment of renal function is crucial in patients with cardiovascular conditions.
  • Identifying individuals at risk for acute or chronic kidney function decline is a clinical priority.

Purpose of the Study:

  • To review the clinical utility of novel biomarkers in managing cardiorenal syndrome.
  • To provide an overview of recent advancements in CRS biomarker research.
  • To identify biomarkers that can improve risk stratification in CRS patients.

Main Methods:

  • Literature review of recent studies on cardiorenal syndrome biomarkers.
  • Analysis of biomarker performance in assessing renal function.
  • Evaluation of biomarkers for predicting renal outcomes in cardiovascular disease.

Main Results:

  • Emerging biomarkers show promise in evaluating renal status in CRS.
  • Certain biomarkers may help identify patients at higher risk of renal deterioration.
  • The clinical application of these biomarkers requires further validation.

Conclusions:

  • New biomarkers offer potential for improved management of cardiorenal syndrome.
  • Further research is needed to establish the definitive role of these biomarkers in clinical practice.
  • Biomarker-guided strategies could enhance patient care in CRS.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
272
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
445
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
152
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
600
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
102
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
212